as 02-21-2025 4:00pm EST
Ashland Inc is a world-wide specialty materials company that serves a wide range of industrial markets. The company has a business-centric operating model and is organized into four distinct segments: life sciences, personal care, specialty additives, and intermediates. Key customers for the firm include pharmaceutical companies and manufacturers of personal care products, food and beverages, and nutraceuticals and supplements. The life sciences segment derives maximum revenue. The company generates its sales from North America, Europe, Asia Pacific, and Latin America, and Others.
Founded: | 1924 | Country: | United States |
Employees: | N/A | City: | WILMINGTON |
Market Cap: | 3.4B | IPO Year: | N/A |
Target Price: | $93.50 | AVG Volume (30 days): | 802.5K |
Analyst Decision: | Buy | Number of Analysts: | 7 |
Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
EPS: | -0.46 | EPS Growth: | N/A |
52 Week Low/High: | $60.60 - $102.50 | Next Earning Date: | 01-28-2025 |
Revenue: | $2,045,000,000 | Revenue Growth: | -4.39% |
Revenue Growth (this year): | -7.15% | Revenue Growth (next year): | 3.01% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
NOVO GUILLERMO | ASH | Chair of the Board and CEO | Jan 31 '25 | Buy | $64.24 | 31,294 | $2,010,326.56 | 31,294 | |
Assis Alessandra Faccin | ASH | SVP and GM, Life Sciences | Jan 31 '25 | Buy | $64.00 | 3,150 | $201,600.00 | 3,150 | |
BONI ERIC N | ASH | VP, Finance & Prinpl Acctg Off | Dec 5 '24 | Sell | $78.07 | 451 | $35,209.57 | 14,182 |
ASH Breaking Stock News: Dive into ASH Ticker-Specific Updates for Smart Investing
Simply Wall St.
2 days ago
Argus Research
4 days ago
Argus Research
4 days ago
Insider Monkey
9 days ago
Simply Wall St.
18 days ago
Argus Research
18 days ago
GuruFocus.com
22 days ago
Zacks
23 days ago
The information presented on this page, "ASH Ashland Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.